Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Haemophilus influenzae type b Polysaccharide Conjugate (Hib conjugate)
- Target
- Hib conjugate
- Molecular classification
- Polysaccharide-protein conjugate
01
Overview
Haemophilus influenzae type b (Hib) polysaccharide conjugate is the active component in Hib conjugate vaccines. The target molecule is the capsular polysaccharide of Hib, specifically polyribosyl-ribitol-phosphate (PRP), which is covalently linked to a protein carrier to enhance immunogenicity and induce a T-cell dependent immune response.
- Other names
- PRP-DHbOCPRP-OMPPRP-TPolyribosyl-ribitol-phosphate conjugate
02
Mechanism of action
Conjugation of polysaccharide with protein carrier to elicit a T-cell dependent immune response, leading to stronger antibody production and long-lasting protection against Hib disease.
03
Biological functions
Induction of T-cell dependent immune responseAntibody productionB cell memory formationProtective immunity against Haemophilus influenzae type b
04
Disease associations
Prevention of Haemophilus influenzae type b invasive diseases (e.g., meningitis, sepsis)
05
Safety considerations
Common vaccine side effectsPotential allergic reactions
06
Interacting drugs
Hib conjugate vaccines
07
Biomarkers
Anti-PRP antibody concentrations
Beyond the preview
Go deeper on Haemophilus influenzae type b Polysaccharide Conjugate (Hib conjugate).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Haemophilus influenzae type b Polysaccharide Conjugate (Hib conjugate).